Once a few mothers saw the difference, everyone in the NICU wanted their child monitored.
In the neonatal wards of Addis Ababa, where newborn mortality has resisted a decade of progress, a small adhesive patch developed at Georgia Tech has begun doing what exhausted nurses and grieving parents could not do alone — watch continuously, without rest, without interruption. Inspired by a personal loss that redirected one researcher's entire career, the device translates the fragile vital signs of newborns into real-time data on a smartphone, asking whether technology shaped by scarcity can finally bend a stubborn curve. It is a story about grief becoming purpose, and about the quiet possibility that a sticker-sized invention might carry the weight of thousands of lives.
- Ethiopia's newborn mortality rate has remained dangerously flat even as broader child mortality has declined, exposing a gap that manual monitoring and paper records have failed to close.
- Nurses in under-resourced NICUs must wake sleeping infants to take vital signs by hand — a labor-intensive process that strains staff, disrupts fragile babies, and leaves dangerous gaps in oversight.
- Georgia Tech researchers Rudy Gleason and Hong Yeo combined expertise in wearable materials and biomedical engineering to build a multi-vital-sign patch designed specifically for the constraints of low-resource settings.
- A pilot study at Ethiopia's top hospital found that once a few mothers agreed to try the device, demand spread rapidly through the NICU — 84 percent of parents said they would use it at home.
- The research team now moves toward scaling deployment across Ethiopian neonatal units, betting that continuous automated monitoring can accomplish what years of other interventions have not.
In a neonatal intensive care unit in Addis Ababa, something quietly shifted. Babies wearing soft patches on their chests and foreheads — devices that looked almost like stickers — no longer needed to be woken for routine vital sign checks. Developed by Georgia Tech researchers, the patches transmit real-time data on heart rate, breathing, temperature, oxygen levels, and cardiac activity directly to a smartphone app, automating what nurses had long done by hand.
The collaboration began when Rudy Gleason, a mechanical engineer with years of work focused on maternal and child mortality in Ethiopia, heard about a wearable cardiac monitor developed by biomedical engineer Hong Yeo. Gleason asked whether they could build something broader — a device measuring multiple vital signs, designed to function where resources are thinnest. The partnership formed immediately.
For Gleason, the work is inseparable from personal loss. In 2009, a baby girl named Kennedy — whom he and his wife were in the process of adopting from Ethiopia — died from a preventable combination of malnutrition and diarrhea before they could bring her home. That grief redirected his career. For fifteen years since, he has focused on building medical devices that can actually function in places where equipment is scarce and expertise is stretched.
Yeo designed the patch using nanomembrane technology, making it soft and flexible enough for a newborn's delicate skin. The system's key contribution is automation: it frees clinical staff from continuous data collection, allowing them to focus on the complex decisions that require human judgment. Yeo describes it as a force multiplier in environments where every nurse's attention is already divided.
The pilot study at Tikur Anbessa Specialized Hospital, published in npj Digital Medicine, revealed an unexpected dynamic. Parents were initially hesitant — but once a few mothers in the NICU agreed to participate, demand spread. By the study's end, 84 percent of Ethiopian parents said they would use the device at home, having experienced fewer disruptions to their babies' sleep and more reliable information about their child's condition.
What distinguishes this project is that it was not designed in a laboratory and then exported. It was shaped in conversation with the place, its constraints, and its people. As the team prepares to scale across Ethiopia's neonatal units, the question they are testing is whether a soft patch and a smartphone app can finally do what years of other interventions have not: bring newborn mortality down.
In a neonatal intensive care unit in Addis Ababa, nurses and parents began noticing something shift. Babies wearing soft patches on their chests and foreheads—devices that looked almost like stickers—no longer needed to be roused from sleep for routine vital sign checks. The patches, developed by researchers at Georgia Tech, were doing the watching instead, transmitting real-time data about heart rate, breathing, temperature, oxygen levels, and electrical activity of the heart directly to a smartphone app. What started as a collaboration between two engineering professors has become a test of whether technology designed for scarcity can actually save lives where resources are thinnest.
Rudy Gleason and Hong Yeo, both faculty members in Georgia Tech's mechanical engineering and biomedical engineering departments, began this work from different starting points but found themselves asking the same question. Yeo had developed a wearable cardiac monitor for children. When Gleason heard about it, he asked whether they could build something broader—a device that would measure not just one vital sign but several, and that would work in Ethiopia, where he had spent years focused on reducing maternal and child mortality. The partnership made immediate sense to both of them.
Gleason's commitment to this work runs deeper than academic interest. In 2009, he and his wife were in the process of adopting a baby girl named Kennedy from Ethiopia. Before they could bring her home, she died from what Gleason describes as a preventable combination of malnutrition and diarrhea. That loss redirected the course of his career. For the past fifteen years, he has channeled his research and teaching toward developing medical devices that could actually function in places where equipment is scarce and expertise is stretched thin.
The device itself reflects this constraint-driven thinking. Yeo designed the wearable patch using nanomembranes—a material technology that allows the device to be soft and flexible enough to conform to a newborn's delicate skin without causing irritation. The chest-mounted patch and forehead-mounted pulse oximeter work together to capture a complete picture of the baby's condition. Critically, the system automates what hospitals currently do by hand: nurses no longer need to manually record vital signs on paper or wake sleeping infants for checks. The smartphone app processes the data continuously, flagging abnormalities in real time. This automation, Yeo notes, acts as a force multiplier—it frees clinical staff from data collection so they can focus on the complex decisions that actually require human judgment.
The pilot study, conducted at Tikur Anbessa Specialized Hospital in Addis Ababa and published in npj Digital Medicine, revealed something unexpected about community adoption. When recruitment began, Ethiopian parents were hesitant to enroll their children. But once a few mothers in the neonatal intensive care unit agreed to participate, the dynamic reversed. Soon, everyone in the NICU community wanted their child monitored by the wearable system. By the end of the study, 84 percent of Ethiopian parents said they would use the device at home. They had experienced the difference: fewer disruptions to their babies' sleep, more reliable monitoring, better information about their child's condition.
The timing of this work matters. Over the past decade, Ethiopia has made progress in reducing overall child mortality rates. But newborn mortality—deaths in the first 28 days of life—has remained stubbornly flat. The country's best hospitals still rely on manual vital sign monitoring and paper-based record-keeping, methods that are labor-intensive and prone to gaps. A device that provides continuous, automated oversight could change that calculus. Both Yeo and Gleason believe the wearable system has the potential to significantly lower newborn mortality rates as they scale the technology across Ethiopia's resource-limited neonatal units.
What makes this story distinct is not just the technology itself but the relationship between the problem and the solution. This was not designed in a lab and then exported to a place that needed it. It was designed in conversation with the place, with the constraints of that place, and with the people who would use it. Yeo speaks of his deep respect for Gleason's commitment to Ethiopia. Gleason speaks of the loss that made this work personal. And the parents in Addis Ababa, having experienced the device, are asking when they can have it. The next phase of this research will determine whether a soft patch and a smartphone app can do what years of other interventions have not yet managed to do: bring newborn mortality down.
Citações Notáveis
This loss redirected my academic teaching, research, and service activities at Georgia Tech. Since then, I've spent most of my career focused on developing resource-appropriate biomedical devices to reduce maternal and child mortality.— Rudy Gleason, Georgia Tech researcher
The built-in automation acts as a force multiplier, freeing clinical staff to focus more on complex decision-making rather than manual data acquisition.— Hong Yeo, Georgia Tech researcher
A Conversa do Hearth Outra perspectiva sobre a história
Why did the parents initially resist, and what changed their minds?
Skepticism is natural when something new arrives in a hospital. But once a few mothers saw that their babies slept better and the monitoring was actually more reliable than the manual checks, the resistance dissolved. It became obvious that this wasn't adding burden—it was removing it.
The device measures five different vital signs. Why is that breadth important in a neonatal unit?
A single vital sign can be misleading. A baby might have a normal heart rate but be struggling to breathe, or normal oxygen levels but a dangerous temperature. The system captures the whole picture continuously, so nothing gets missed in the gaps between manual checks.
You mention that 84 percent of parents wanted to use it at home. That's striking. What does home use mean for a newborn?
It means parents can monitor their baby after discharge, when complications often emerge and when getting back to a hospital might take hours. Early detection of problems at home could prevent deaths that currently happen in the interval between leaving the hospital and returning to care.
Gleason's daughter Kennedy died in 2009. Does that loss still shape how he approaches this work?
It's the foundation of everything. He's not solving an abstract problem. He's trying to prevent what happened to Kennedy from happening to other families. That clarity of purpose changes how you design, how you listen to communities, how you persist when progress is slow.
The automation aspect seems crucial—freeing nurses from data entry so they can think. How does that actually play out in a busy NICU?
In resource-limited settings, nurses are already stretched. If you can eliminate the manual recording and paper tracking, you've given them back time and mental space for the decisions that actually require expertise. The machine does the watching; the human does the thinking.
What happens next? Is this ready to scale?
The pilot proved the concept works and that communities want it. Now comes the harder part: manufacturing at scale, training staff across multiple hospitals, integrating it into existing workflows, and proving it actually reduces mortality rates in real-world conditions. That's years of work.